This is a purely administrative corporate action with no fundamental impact. Monitor for any subsequent capital-raising announcements that often follow reverse splits, but the filing itself does not signal a change in outlook.
Price Chart
Executive Summary
Alterity Therapeutics filed a 6-K confirming a 1-for-50 reverse share consolidation, effective June 3, 2026, with temporary ASX ticker ATHDA through June 11. The consolidation reduces share count proportionally and adjusts the share price, but does not alter the company's fundamental value or pipeline status.
Key Facts
- Share consolidation on a 1-for-50 basis approved at EGM on May 29, 2026, now being actioned.
- Trading on ASX under temporary code ATHDA from June 3 to June 11, 2026 on a deferred settlement basis.
- Normal trading under ASX code ATH resumes June 12, 2026.
- Listed options (ATHO, ATHOA) also trade under temporary codes ATHDB and ATHDC on deferred settlement.
- Fractional entitlements rounded up to nearest whole number (minimum 1 security).
- Company remains a clinical-stage biotech preparing for Phase 3 MSA trial; no change to business or pipeline.
Financial Impact
No change to market cap or enterprise value; share price adjusts proportionally to consolidation ratio.
Risk Factors
- Reverse splits are often followed by dilutive offerings, though none announced here.
- Low liquidity during deferred settlement period (June 3-11) may cause wider bid-ask spreads.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-019479 |
| Exhibit: ex_972197.htm | 0001437749-26-019479 |
| Document: 0001437749-26-019479-index-headers.html | 0001437749-26-019479 |
| Document: 0001437749-26-019479-index.html | 0001437749-26-019479 |
| Document: 0001437749-26-019479.txt | 0001437749-26-019479 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 9, 2026 20w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▼ −1.39% | $0.2500 (+354.55%) |
Jun 4, 2026 20w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▲ +1.37% | $0.2500 (+354.55%) |
Jun 3, 2026 20w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▲ +1.00% | $0.2500 (+354.55%) |
May 29, 2026 21w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▲ +1.79% | $0.2500 (+354.55%) |
Apr 30, 2026 25w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▼ −5.23% | $0.2500 (+354.55%) |
Apr 29, 2026 25w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −6.05% | $0.2500 (+22627.27%) |
Apr 27, 2026 26w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −4.95% | $0.2500 (+22627.27%) |
Apr 22, 2026 26w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −4.22% | $0.2500 (+22627.27%) |
Apr 21, 2026 27w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −4.21% | $0.2500 (+22627.27%) |
Apr 20, 2026 27w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −4.22% | $0.2500 (+22627.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers